The start of the new week brings no respite to the US stock market. Pre-session trading saw a sell-off of key technology stocks, including Alphabet (-2.6%), Tesla (-4.0%), Microsoft (-1.5%), Apple (-1.3%), Meta (-2.65%), Nvidia (-2.6%), and Amazon (-2.1%). Analysts are also beginning to revise their expectations for the S&P 500's growth this year. JP Morgan suggests that its earlier conservative forecast of 6,500 points may not materialize due to high volatility and uncertainty.
Forecasts for the year-end S&P 500 level among Wall Street strategists have ceased to rise, a rather negative sign from a historical perspective. Source: Bloomberg Finance LP,
From a technical standpoint, very weak signals are also observed. The US500 crossed below its 200-session average last week and is currently trading approximately 1.3% below it. On Friday, the 250-session average was also tested, currently at 5,670 points. A similar situation was last observed in October 2023, when the US500 fell by about 4% below the 200-session average and 2.5% below the 250-session average. In April 2022, a prolonged descent below these averages was seen, with the US500 remaining below these technical indicators for nearly a year.
The US500 has lost approximately 7.5% from its peaks in the second half of February and has fallen below 5,700 points. Source: xStation5
Daily Summary: U.S. stock indices are climbing following the PPI data
US OPEN: Wall Street Rallies on Soft PPI Data
Morning wrap: Sentiment on Wall Street slightly eases, US dollar under pressure (14.04.2026)
Daily summary: Stocks back in the green on hopes for US-Iran talks, dollar resumes losing streak (13.04.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
